Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dexamethasone sustained drug delivery implant for the treatment of severe uveitis.

× No keyword cloud information.

9 in total

Review 1. Management of sight-threatening uveitis: new therapeutic options.

Authors: Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal: Drugs Date: 2005 Impact factor: 9.546

2. Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models.

Authors: Masuhiro Kodama; Jiro Numaga; Atsushi Yoshida; Toshikatsu Kaburaki; Tetsuro Oshika; Yujiro Fujino; Guey-Shuang Wu; Narsing A Rao; Hidetoshi Kawashima
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2003-09-04 Impact factor: 3.117

3. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.

Authors: A A Okada; T Wakabayashi; Y Morimura; S Kawahara; E Kojima; Y Asano; T Hida
Journal: Br J Ophthalmol Date: 2003-08 Impact factor: 4.638

Review 4. Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Authors: Blake A Booth; Lori Vidal Denham; Saadallah Bouhanik; Jean T Jacob; James M Hill
Journal: Drugs Aging Date: 2007 Impact factor: 3.923

Review 8. Fluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic management.

Authors: Matthew V Brumm; Quan Dong Nguyen
Journal: Int J Nanomedicine Date: 2007

9. Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence.

Authors: Saanwalshah Samir Saincher; Chloe Gottlieb
Journal: J Ophthalmic Inflamm Infect Date: 2020-01-10

9 in total

Dexamethasone sustained drug delivery implant for the treatment of severe uveitis.

Review 1. Management of sight-threatening uveitis: new therapeutic options.

2. Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models.

3. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.

Review 4. Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Review 5. Corticosteroid implants for chronic non-infectious uveitis.

6. Dexamethasone intravitreal implant for the treatment of noninfectious uveitis.

7. Sustained release intraocular drug delivery devices for treatment of uveitis.

Review 8. Fluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic management.

9. Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence.